BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2076 related articles for article (PubMed ID: 21266920)

  • 21. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Liang RB; Yang J; Zeng TS; Long H; Fu JH; Zhang LJ; Lin P; Wang X; Rong TH; Hou X; Yang HX
    Ann Surg Oncol; 2018 Oct; 25(11):3300-3307. PubMed ID: 30083835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid?
    Aokage K; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    Lung Cancer; 2010 Nov; 70(2):163-7. PubMed ID: 20236727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection.
    Okada M; Tsubota N; Yoshimura M; Miyamoto Y
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):949-53. PubMed ID: 9832685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value and significance of subcarinal and superior mediastinal lymph node metastasis in lower lobe tumours.
    Uehara H; Sakao Y; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
    Eur J Cardiothorac Surg; 2010 Oct; 38(4):498-502. PubMed ID: 20381371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer.
    Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.
    Ilic N; Petricevic A; Arar D; Kotarac S; Banovic J; Ilic NF; Tripkovic A; Grandic L
    J Thorac Oncol; 2007 Nov; 2(11):1018-21. PubMed ID: 17975493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors influencing lymph nodes metastasis in lung cancer with stage I, II or IIIA].
    Hirayama T; Kaneda Y; Nawata S; Tanaka S; Esato K
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Oct; 38(10):2049-55. PubMed ID: 2176232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between the pathways of the lymphatic drainage into the mediastinal nodes and the survival rate for N2 lung cancers underwent curative resection].
    Ohta S; Inaba H; Nishimura T; Takamochi K; Ishida I
    Kyobu Geka; 1998 Mar; 51(5):357-62; discussion 362-4. PubMed ID: 9594492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases.
    Maggi G; Casadio C; Cianci R; Molinatti M; Filosso PL; Nicolosi M; Oliaro A
    Int Surg; 1993; 78(3):213-7. PubMed ID: 8276543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 104.